These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32706014)

  • 1. A general method for cultivating single crystals from melt microdroplets.
    Ou X; Li X; Rong H; Yu L; Lu M
    Chem Commun (Camb); 2020 Sep; 56(69):9950-9953. PubMed ID: 32706014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of melting temperature and enthalpy of drug crystals: theoretical aspects.
    Hasa D; Voinovich D; Perissutti B; Grassi G; Fiorentino S; Farra R; Abrami M; Colombo I; Grassi M
    Eur J Pharm Sci; 2013 Sep; 50(1):17-28. PubMed ID: 23567466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin.
    Feng T; Pinal R; Carvajal MT
    J Pharm Sci; 2008 Aug; 97(8):3207-21. PubMed ID: 17990307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization kinetics of amorphous griseofulvin by pattern fitting procedure using X-ray diffraction data.
    Yamamura S; Takahira R; Momose Y
    Pharm Res; 2007 May; 24(5):880-7. PubMed ID: 17372690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous preparation of polymer coated drug crystals by solid hollow fiber membrane-based cooling crystallization.
    Chen D; Singh D; Sirkar KK; Pfeffer R
    Int J Pharm; 2016 Feb; 499(1-2):395-402. PubMed ID: 26772536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rich polymorphism in nicotinamide revealed by melt crystallization and crystal structure prediction.
    Li X; Ou X; Wang B; Rong H; Wang B; Chang C; Shi B; Yu L; Lu M
    Commun Chem; 2020 Nov; 3(1):152. PubMed ID: 36703331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supercritical fluid crystallization of griseofulvin: crystal habit modification with a selective growth inhibitor.
    Jarmer DJ; Lengsfeld CS; Anseth KS; Randolph TW
    J Pharm Sci; 2005 Dec; 94(12):2688-702. PubMed ID: 16258994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous synthesis of polymer-coated drug particles by porous hollow fiber membrane-based antisolvent crystallization.
    Chen D; Singh D; Sirkar KK; Pfeffer R
    Langmuir; 2015; 31(1):432-41. PubMed ID: 25552289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
    Feng T; Bates S; Carvajal MT
    Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure determination of phase II of the antifungal drug griseofulvin by powder X-ray diffraction.
    Mahieu A; Willart JF; Guerain M; Derollez P; Danéde F; Descamps M
    Acta Crystallogr C Struct Chem; 2018 Mar; 74(Pt 3):321-324. PubMed ID: 29504561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-crystal formation between poly(ethylene glycol) and a small molecular drug griseofulvin.
    Zhong Z; Guo C; Chen L; Xu J; Huang Y
    Chem Commun (Camb); 2014 Jun; 50(48):6375-8. PubMed ID: 24803004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
    Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
    Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin.
    Yang D; Kulkarni R; Behme RJ; Kotiyan PN
    Int J Pharm; 2007 Feb; 329(1-2):72-80. PubMed ID: 17027207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective detection and quantitation of organic molecule crystallization by second harmonic generation microscopy.
    Wanapun D; Kestur US; Kissick DJ; Simpson GJ; Taylor LS
    Anal Chem; 2010 Jul; 82(13):5425-32. PubMed ID: 20515064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of PEG molecular weights on the thermal stability and dissolution behaviors of griseofulvin-PEG crystalline inclusion complexes.
    Yang X; Zhong Z; Huang Y
    Int J Pharm; 2016 Jul; 508(1-2):51-60. PubMed ID: 27173824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mobility, thermodynamics and stability of griseofulvin's ultraviscous and glassy states from dynamic heat capacity.
    Tombari E; Presto S; Johari GP; Shanker RM
    Pharm Res; 2008 Apr; 25(4):902-12. PubMed ID: 17899326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the polymorphism of griseofulvin: identification of two additional polymorphs.
    Mahieu A; Willart JF; Dudognon E; Eddleston MD; Jones W; Danède F; Descamps M
    J Pharm Sci; 2013 Feb; 102(2):462-8. PubMed ID: 23132509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single particle nonlinear optical imaging of trace crystallinity in an organic powder.
    Wanapun D; Kestur US; Taylor LS; Simpson GJ
    Anal Chem; 2011 Jun; 83(12):4745-51. PubMed ID: 21598920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of pharmaceutical drug crystallites in solid dispersions by transmission electron microscopy.
    Ricarte RG; Lodge TP; Hillmyer MA
    Mol Pharm; 2015 Mar; 12(3):983-90. PubMed ID: 25699402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.